Takeo Yoshikawa

Affiliations: 
Laboratory for Molecular Psychiatry RIKEN Center for Brain Science 
Google:
"Takeo Yoshikawa"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kushima I, Nakatochi M, Aleksic B, et al. (2022) Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder. Biological Psychiatry
Uezato A, Jitoku D, Shimazu D, et al. (2022) Differential genetic associations and expression of PAPST1/SLC35B2 in bipolar disorder and schizophrenia. Journal of Neural Transmission (Vienna, Austria : 1996)
Balan S, Iwayama Y, Ohnishi T, et al. (2021) A loss-of-function variant in SUV39H2 identified in autism-spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin β-cluster genes in the developing brain. Molecular Psychiatry
Hara T, Toyoshima M, Hisano Y, et al. (2021) Glyoxalase I disruption and external carbonyl stress impair mitochondrial function in human induced pluripotent stem cells and derived neurons. Translational Psychiatry. 11: 275
Ohnishi T, Kiyama Y, Arima-Yoshida F, et al. (2021) Cooperation of LIM domain-binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia. Embo Molecular Medicine. e12574
Balan S, Ohnishi T, Watanabe A, et al. (2021) Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia. Schizophrenia Bulletin
Ogata S, Hashizume K, Hayase Y, et al. (2021) Potential involvement of DSCAML1 mutations in neurodevelopmental disorders. Genes to Cells : Devoted to Molecular & Cellular Mechanisms
Oishi K, Niitsu T, Kanahara N, et al. (2021) Genetic risks of schizophrenia identified in a matched case-control study. European Archives of Psychiatry and Clinical Neuroscience. 271: 775-781
Wada Y, Maekawa M, Ohnishi T, et al. (2020) Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia. Ebiomedicine. 103130
Hayase Y, Amano S, Hashizume K, et al. (2020) Down syndrome cell adhesion molecule like-1 (DSCAML1) links the GABA system and seizure susceptibility. Acta Neuropathologica Communications. 8: 206
See more...